Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2001 1
2002 4
2003 3
2004 1
2005 3
2007 1
2008 3
2009 2
2010 5
2011 2
2012 7
2013 7
2014 9
2015 8
2016 12
2017 10
2018 12
2019 15
2020 18
2021 21
2022 16
2023 25
2024 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Brown PD, et al. Among authors: hadjipanayis cg. Lancet Oncol. 2017 Aug;18(8):1049-1060. doi: 10.1016/S1470-2045(17)30441-2. Epub 2017 Jul 4. Lancet Oncol. 2017. PMID: 28687377 Free PMC article. Clinical Trial.
Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.
Barrette AM, Ronk H, Joshi T, Mussa Z, Mehrotra M, Bouras A, Nudelman G, Jesu Raj JG, Bozec D, Lam W, Houldsworth J, Yong R, Zaslavsky E, Hadjipanayis CG, Birtwistle MR, Tsankova NM. Barrette AM, et al. Among authors: hadjipanayis cg. Neuro Oncol. 2022 May 4;24(5):694-707. doi: 10.1093/neuonc/noab244. Neuro Oncol. 2022. PMID: 34657158 Free PMC article.
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.
Casillo SM, Gatesman TA, Chilukuri A, Varadharajan S, Johnson BJ, David Premkumar DR, Jane EP, Plute TJ, Koncar RF, Stanton AJ, Biagi-Junior CAO, Barber CS, Halbert ME, Golbourn BJ, Halligan K, Cruz AF, Mansi NM, Cheney A, Mullett SJ, Land CV, Perez JL, Myers MI, Agrawal N, Michel JJ, Chang YF, Vaske OM, MichaelRaj A, Lieberman FS, Felker J, Shiva S, Bertrand KC, Amankulor N, Hadjipanayis CG, Abdullah KG, Zinn PO, Friedlander RM, Abel TJ, Nazarian J, Venneti S, Filbin MG, Gelhaus SL, Mack SC, Pollack IF, Agnihotri S. Casillo SM, et al. Among authors: hadjipanayis cg. Cell Rep. 2024 Jan 23;43(1):113557. doi: 10.1016/j.celrep.2023.113557. Epub 2023 Dec 18. Cell Rep. 2024. PMID: 38113141 Free article.
Use of Intraoperative Fluorophores.
Schupper AJ, Hadjipanayis C. Schupper AJ, et al. Among authors: hadjipanayis c. Neurosurg Clin N Am. 2021 Jan;32(1):55-64. doi: 10.1016/j.nec.2020.08.001. Epub 2020 Nov 5. Neurosurg Clin N Am. 2021. PMID: 33223026 Review.
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Palmer JD, et al. Among authors: hadjipanayis cg. JAMA Oncol. 2022 Dec 1;8(12):1809-1815. doi: 10.1001/jamaoncol.2022.5049. JAMA Oncol. 2022. PMID: 36264568 Free PMC article. Clinical Trial.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Fluorescence-guided surgery for high-grade gliomas.
Lakomkin N, Hadjipanayis CG. Lakomkin N, et al. Among authors: hadjipanayis cg. J Surg Oncol. 2018 Aug;118(2):356-361. doi: 10.1002/jso.25154. Epub 2018 Aug 19. J Surg Oncol. 2018. PMID: 30125355 Review.
Laser hyperthermia: Past, present, and future.
Schupper AJ, Chanenchuk T, Racanelli A, Price G, Hadjipanayis CG. Schupper AJ, et al. Among authors: hadjipanayis cg. Neuro Oncol. 2022 Nov 2;24(Suppl 6):S42-S51. doi: 10.1093/neuonc/noac208. Neuro Oncol. 2022. PMID: 36322099 Free PMC article. Review.
Neurosurgical Applications of Magnetic Hyperthermia Therapy.
Rivera D, Schupper AJ, Bouras A, Anastasiadou M, Kleinberg L, Kraitchman DL, Attaluri A, Ivkov R, Hadjipanayis CG. Rivera D, et al. Among authors: hadjipanayis cg. Neurosurg Clin N Am. 2023 Apr;34(2):269-283. doi: 10.1016/j.nec.2022.11.004. Epub 2023 Jan 30. Neurosurg Clin N Am. 2023. PMID: 36906333 Free PMC article. Review.
5-ALA fluorescence-guided surgery of CNS tumors.
Hadjipanayis CG, Stummer W, Sheehan JP. Hadjipanayis CG, et al. J Neurooncol. 2019 Feb;141(3):477-478. doi: 10.1007/s11060-019-03109-y. J Neurooncol. 2019. PMID: 30671710 No abstract available.
191 results